JP2024512483A5 - - Google Patents

Info

Publication number
JP2024512483A5
JP2024512483A5 JP2023557131A JP2023557131A JP2024512483A5 JP 2024512483 A5 JP2024512483 A5 JP 2024512483A5 JP 2023557131 A JP2023557131 A JP 2023557131A JP 2023557131 A JP2023557131 A JP 2023557131A JP 2024512483 A5 JP2024512483 A5 JP 2024512483A5
Authority
JP
Japan
Prior art keywords
pkp2
fold
cardiomyocytes
gene therapy
isoform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023557131A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024512483A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/057145 external-priority patent/WO2022195074A2/en
Publication of JP2024512483A publication Critical patent/JP2024512483A/ja
Publication of JP2024512483A5 publication Critical patent/JP2024512483A5/ja
Pending legal-status Critical Current

Links

JP2023557131A 2021-03-19 2022-03-18 遺伝子治療組成物及び不整脈原性右室心筋症の治療 Pending JP2024512483A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163163393P 2021-03-19 2021-03-19
US63/163,393 2021-03-19
PCT/EP2022/057145 WO2022195074A2 (en) 2021-03-19 2022-03-18 Gene therapy composition and treatment of right ventricular arrhythmogenic cardiomyopathy

Publications (2)

Publication Number Publication Date
JP2024512483A JP2024512483A (ja) 2024-03-19
JP2024512483A5 true JP2024512483A5 (cg-RX-API-DMAC7.html) 2025-03-27

Family

ID=81384690

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023557131A Pending JP2024512483A (ja) 2021-03-19 2022-03-18 遺伝子治療組成物及び不整脈原性右室心筋症の治療

Country Status (12)

Country Link
US (1) US20240042059A1 (cg-RX-API-DMAC7.html)
EP (1) EP4308172A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024512483A (cg-RX-API-DMAC7.html)
KR (1) KR20230159471A (cg-RX-API-DMAC7.html)
CN (1) CN117715660A (cg-RX-API-DMAC7.html)
AU (1) AU2022239846A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023018944A2 (cg-RX-API-DMAC7.html)
CA (1) CA3212043A1 (cg-RX-API-DMAC7.html)
IL (1) IL305959A (cg-RX-API-DMAC7.html)
MX (1) MX2023011035A (cg-RX-API-DMAC7.html)
TW (1) TW202300180A (cg-RX-API-DMAC7.html)
WO (1) WO2022195074A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114450411A (zh) 2019-04-01 2022-05-06 特纳亚治疗股份有限公司 具有工程化衣壳的腺相关病毒
WO2022032226A1 (en) 2020-08-07 2022-02-10 Spacecraft Seven, Llc Plakophilin-2 (pkp2) gene therapy using aav vector
US11781156B2 (en) 2020-10-09 2023-10-10 Tenaya Therapeutics, Inc. Plakophillin-2 gene therapy methods and compositions
JP7415042B2 (ja) 2020-10-09 2024-01-16 テナヤ セラピューティクス, インコーポレイテッド プラコフィリン2遺伝子治療の方法および組成物
CN115851751A (zh) * 2022-12-21 2023-03-28 百世诺(北京)医疗科技有限公司 肥厚型心肌病变异基因tnnt2及其应用
WO2025189238A1 (en) * 2024-03-12 2025-09-18 Murdoch Children's Research Institute Treatment methods for muscle-associated diseases
WO2025238184A1 (en) * 2024-05-15 2025-11-20 Stichting Amsterdam UMC Scn10a-short gene therapy to restore cardiac impulse conduction and to protect against cardiac arrhythmia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102298579B1 (ko) * 2013-05-21 2021-09-07 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도
WO2019060619A1 (en) * 2017-09-20 2019-03-28 The Regents Of The University Of California STRATEGY OF GENE THERAPY FOR RESTORING ELECTRICAL AND CARDIAC FUNCTION AND CARDIAC STRUCTURE IN ARYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
US12098385B2 (en) * 2017-09-20 2024-09-24 The Regents Of The University Of California Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy
CN109004092A (zh) 2018-06-29 2018-12-14 云谷(固安)科技有限公司 有机电致发光器件和有机电致发光装置
TWI897882B (zh) * 2019-09-20 2025-09-21 英商Ucl商業有限責任公司 右心室心律失常性心肌病之基因療法組合物及治療
WO2022032226A1 (en) * 2020-08-07 2022-02-10 Spacecraft Seven, Llc Plakophilin-2 (pkp2) gene therapy using aav vector
US11781156B2 (en) * 2020-10-09 2023-10-10 Tenaya Therapeutics, Inc. Plakophillin-2 gene therapy methods and compositions
JP7415042B2 (ja) * 2020-10-09 2024-01-16 テナヤ セラピューティクス, インコーポレイテッド プラコフィリン2遺伝子治療の方法および組成物

Similar Documents

Publication Publication Date Title
JP2022549140A5 (cg-RX-API-DMAC7.html)
US11613766B2 (en) Adeno-associated virus variant capsids and methods of use thereof
JP2022508182A5 (cg-RX-API-DMAC7.html)
US12257317B2 (en) Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy
Grieger et al. Adeno-associated virus vectorology, manufacturing, and clinical applications
JP2021512649A5 (cg-RX-API-DMAC7.html)
JP2022190081A5 (cg-RX-API-DMAC7.html)
RU2017125234A (ru) Конструкции нуклеиновой кислоты и векторы для генотерапии для применения для лечения болезни вильсона и других состояний
RU2018116076A (ru) Модифицированные гены атаксии фридрейха и векторы для генной терапии
US20040180440A1 (en) Modified AAV
JP2020528734A5 (cg-RX-API-DMAC7.html)
CN112823210A (zh) 用于治疗肌营养不良的肌肉特异性微小肌营养不良蛋白的腺相关病毒载体递送
AU2019250249A1 (en) Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases
FI3628334T3 (fi) Geenihoito verkkokalvon pigmenttirappeuma
JP2021514659A (ja) Aavキメラ
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2022551744A5 (cg-RX-API-DMAC7.html)
US20240269161A1 (en) Methods and compositions for tau reduction gene therapy
JP2020509786A5 (cg-RX-API-DMAC7.html)
JP2021519065A5 (cg-RX-API-DMAC7.html)
IL292264B1 (en) Aav transfer cassette
JP2018515102A (ja) スペーサーを含む核酸分子およびその使用の方法
JP2021520811A5 (cg-RX-API-DMAC7.html)
CN118660969A (zh) 使用aav载体的亲联蛋白-2(jph2)基因疗法
JP2023541443A5 (cg-RX-API-DMAC7.html)